The renal denervation bubble collapsed due to a single trial—SYMPLICITY HTN-3, but this trial’s findings went against the grain, Horst Sievert (Frankfurt, Germany) tells Cardiovascular News at CRT 2019. Sievert shares early results of alcohol-mediated renal denervation, which were presented as a late-breaking abstract at the conference.
